Opioid Agonist and Antagonist Effects on Opioid Dependence
| Status: | Terminated |
|---|---|
| Conditions: | Gastrointestinal |
| Therapuetic Areas: | Gastroenterology |
| Healthy: | No |
| Age Range: | 18 - 55 |
| Updated: | 1/13/2017 |
| Start Date: | January 2004 |
| End Date: | February 2006 |
The Variability of Agonist and Antagonist Effects as a Function of Level of Physical Dependence
The purpose of this study is to examine the acute agonist and antagonist effects of a full
opioid agonist medication, an opioid antagonist medication, and a partial opioid agonist
medication in individuals who have different levels of physical opioid dependence.
opioid agonist medication, an opioid antagonist medication, and a partial opioid agonist
medication in individuals who have different levels of physical opioid dependence.
The pharmacological effects of opioids in opioid dependent individuals can vary as a
function of the characteristics of the opioid being studied (e.g., whether it is an agonist,
partial agonist, or antagonist; the dose administered; and the route of administration).
Another important set of factors influencing the effects produced by opioids is the
characteristics of the organism to which the opioid is being administered. One such
characteristic is the level of physical dependence in individuals.
Participants in this study will be maintained on different dose levels of an opioid agonist
(methadone). The participant will be challenged with a prototypic opioid agonist,
antagonist, and a mixed agonist-antagonist with partial agonist features in order to
determine the effects that each has on the human body.
function of the characteristics of the opioid being studied (e.g., whether it is an agonist,
partial agonist, or antagonist; the dose administered; and the route of administration).
Another important set of factors influencing the effects produced by opioids is the
characteristics of the organism to which the opioid is being administered. One such
characteristic is the level of physical dependence in individuals.
Participants in this study will be maintained on different dose levels of an opioid agonist
(methadone). The participant will be challenged with a prototypic opioid agonist,
antagonist, and a mixed agonist-antagonist with partial agonist features in order to
determine the effects that each has on the human body.
Inclusion Criteria:
- Active opioid dependence
- Qualifies for opioid agonist treatment (e.g., methadone or buprenorphine)
- Fulfills DSM-IV diagnostic criteria for opioid dependence
Exclusion Criteria:
- Significant medical problems, including insulin dependent diabetes mellitus
- Non-substance use psychiatric disorders (e.g., schizophrenia)
- Currently seeking treatment for substance abuse
We found this trial at
1
site
Click here to add this to my saved trials
